XML 26 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Non-redeemable Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 27, 2020   32,545          
Beginning balance at Dec. 27, 2020 $ (266,939) $ 453 $ 254,103 $ (14,168) [1] $ 219,158 $ (741,724) $ 15,239
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [2] 122,346       120,016   2,330
Other comprehensive income (loss), net of tax 4,197     4,197 [1]      
Repurchase and conversion of Series B Convertible Preferred Stock (in shares)   3,489          
Repurchase and conversion of Series B Convertible Preferred Stock 64,168 $ 35 174,631   (110,498)    
Cash dividends on common stock (40,356)   158   (40,514)    
Cash dividends on preferred stock $ (4,121)       (4,121)    
Exercise of stock options (in shares) 212 212          
Exercise of stock options $ 11,969 $ 2 11,967        
Acquisition of Company common stock (in shares) (594) (594)          
Acquisition of Company common stock $ (72,499)         (72,499)  
Stock-based compensation expense 16,919   16,919        
Issuance of restricted stock (in shares)   132          
Issuance of restricted stock 0   (6,970)     6,970  
Tax effect of restricted stock awards (5,847)   (5,847)        
Distributions to noncontrolling interests (2,357)           (2,357)
Other (in shares)   13          
Other 62   165   (884) 781  
Ending balance (in shares) at Dec. 26, 2021   35,797          
Ending balance at Dec. 26, 2021 (172,458) $ 490 445,126 (9,971) [1],[3] 183,157 (806,472) 15,212
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [4] 68,775       67,772   1,003
Other comprehensive income (loss), net of tax (164)     (164) [3]      
Cash dividends on common stock $ (54,767)   210   (54,977)    
Exercise of stock options (in shares) 82 82          
Exercise of stock options $ 4,036 $ 1 4,035        
Acquisition of Company common stock (in shares) (1,343) (1,343)          
Acquisition of Company common stock $ (125,000)         (125,000)  
Stock-based compensation expense 18,388   18,388        
Issuance of restricted stock (in shares)   285          
Issuance of restricted stock 0   (8,443)     8,443  
Tax effect of restricted stock awards (in shares)   (94)          
Tax effect of restricted stock awards (9,546)   (9,546)        
Distributions to noncontrolling interests (486)           (486)
Other (in shares)   9          
Other $ 558   59   (96) 595  
Ending balance (in shares) at Dec. 25, 2022 34,700 34,736          
Ending balance at Dec. 25, 2022 $ (270,664) $ 491 449,829 (10,135) [3],[5] 195,856 (922,434) 15,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [6] 82,601       82,098   503
Other comprehensive income (loss), net of tax 2,332     2,332 [5]      
Dividends on common stock $ (58,806)   121   (58,927)    
Exercise of stock options (in shares) 43 43          
Exercise of stock options $ 2,252 $ 1 2,251        
Acquisition of Company common stock (in shares) (2,523) (2,523) [7]          
Acquisition of Company common stock [7] $ (212,444)         (212,444)  
Stock-based compensation expense 17,924   17,924        
Issuance of restricted stock (in shares)   240          
Issuance of restricted stock 0   (7,149)     7,149  
Tax effect of restricted stock awards (in shares)   (77)          
Tax effect of restricted stock awards (6,416)   (6,416)        
Distributions to noncontrolling interests (756)           (756)
Other (in shares)   69          
Other $ 361   (4,270)   0 4,631  
Ending balance (in shares) at Dec. 31, 2023 32,500 32,488          
Ending balance at Dec. 31, 2023 $ (443,616) $ 492 $ 452,290 $ (7,803) [5] $ 219,027 $ (1,123,098) $ 15,476
[1] At December 26, 2021, the accumulated other comprehensive loss of $9,971 was comprised of net unrealized foreign currency translation loss of $4,869 and a net unrealized loss on the interest rate swap agreements of $5,102.
[2] Net income to the Company for the year ended December 26, 2021 excludes $2,609 allocable to the redeemable noncontrolling interests for our joint venture arrangements.
[3] At December 25, 2022, the accumulated other comprehensive loss of $10,135 was comprised of net unrealized foreign currency translation loss of $8,696 and a net unrealized loss on the interest rate swap agreements of $1,439.
[4] Net income to the Company for the year ended December 25, 2022 excludes $574 allocable to the redeemable noncontrolling interests for our joint venture arrangements.
[5] At December 31, 2023, the accumulated other comprehensive loss of $7,803 was comprised of net unrealized foreign currency translation loss of $7,490 and a net unrealized loss on the interest rate swap agreements of $314.
[6] Net income to the Company for the year ended December 31, 2023 excludes $198 allocable to the redeemable noncontrolling interests for our joint venture arrangements.
[7] Acquisition of Company common stock for the year ended December 31, 2023 includes $2,804 of transaction costs directly attributable to share repurchases, including a 1% excise tax incurred under the Inflation Reduction Act of 2022.